As AI-driven diagnostics, drug discovery, and personalized medicine advance, the ethical review and regulatory approval processes for new biotech innovations are becoming overwhelmed and prohibitively slow. BioEthics Gatekeeper is an AI-powered platform that assists biotech firms and regulatory bodies (e.g., IRB, FDA) in the ethical review and compliance process by analyzing research protocols, identifying potential ethical conflicts, predicting regulatory hurdles, and generating initial compliance reports. It accelerates safe and ethical innovation.
The acceleration of AI and genomic research is creating unprecedented ethical dilemmas and regulatory backlogs. New AI models can now analyze complex scientific literature and ethical guidelines to identify subtle risks and ensure protocols align with evolving standards, addressing a critical bottleneck in getting life-saving innovations to market.
Biotech startups, pharmaceutical companies, academic research institutions, and regulatory bodies (e.g., IRBs, Ethics Committees). They will pay to accelerate research, ensure ethical conduct, and navigate complex regulatory landscapes more efficiently.
Subscription-based licensing for research institutions and biotech firms, tiered by the volume and complexity of protocols analyzed. API access for integration into internal compliance systems of larger organizations and regulatory agencies.